Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-03

Clinical Trial Update: Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of ranolazine on myocardial perfusion during exercise, assessed by serial quantitative SPECT imaging; results posted in 2014…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Myocardial Perfusion Imaging, Myocardial Ischemia | Phase 4 | Status: COMPLETED | Results posted: 2014-09-03